Antimicrobial Susceptibility Testing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028, Segmented By Product (Manual Tests, (MIC Strips, Susceptibility Testing Disks, Susceptibility Plates) Automated Instruments, and Consumables & Media), By Technique (Automated AST, Etest Method, Dilution, Disk Diffusion, and Others), By Application (Drug Development, Susceptibility Testing, and Others), By End User (Hospitals, Diagnostic Laboratories, BioTechnique & Pharmaceutical Companies, and Others), By Region and Competition

Antimicrobial susceptibility testing (AST) is a laboratory procedure used to determine the susceptibility or resistance of a bacterial or fungal isolate to various antimicrobial agents. In-vitro antimicrobial susceptibility testing can be performed using various type of formats such as disk diffusion, agar dilution, broth microdilution, broth macrodilution, and a concentration gradient test. The results of Antimicrobial Susceptibility Testing (AST) are used to guide the choice of appropriate antimicrobial therapy for the patient. Susceptibility results are reported as the minimum inhibitory concentration (MIC), which is the lowest concentration of the antimicrobial agent that inhibits the growth of the organism. Several characteristics such as whether the organism is susceptible, intermediate, or resistant to the antimicrobial agent can be determined using MIC values. According to a report by the World Health Organization (WHO), antimicrobial resistance is a significant threat to global health, and it is estimated that by 2050, it could cause more deaths than cancer. The market for antimicrobial susceptibility testing is driven by the increase in prevalence of infectious diseases. Several infectious disease outbreaks such as Shigella, Neisseria gonorrhoeae, Neisseria meningitides, and Salmonella serotype typhi which has been attributed to lack of water supply, sanitation, and hygiene are rising the demand for antimicrobial susceptibility testing in the forecast period. Moreover, increase in geriatric population across various parts of the country along with certain type of diseases influenza, pneumonia, shingles, and others which are associated with them in their elder age is further expected to propel the growth of global antimicrobial susceptibility testing market in the forecast period.

Increase in Prevalence of Infectious Diseases

Infectious diseases are certain kind of disorders caused by pathogenic microorganisms, such as bacteria, viruses, fungi, parasites, and prions. These microorganisms can invade the human body, multiply, and cause disease by damaging tissues, secreting toxins, or triggering an immune response that results in inflammation. Influenza, malaria, tuberculosis, dengue, and others are some of the most commonly prevailing infectious diseases across the world. Antimicrobial susceptibility testing is a critical tool for determining the appropriate antimicrobial therapy for infectious diseases. When a patient gets affected with infectious disease, sample of the bacteria is taken and is sent to the laboratory for antimicrobial susceptibility testing. Results obtained from the test are used to guide the selection of an appropriate antibiotic for treating the patient's infection. In recent times, COVID-19 pandemic caused by the SARS-CoV-2 virus have emerged as the leading infectious disease affecting many people across the world. According to the report published by Worldometer in 2023, it has been observed that in 2021 around 106,771,290 cases of COVID-19 were reported in United States of America causing 1,162,471 deaths, followed by 44,971,469 cases of COVID-19 in India causing 531,692 deaths, 40,021,949 cases of COVID-19 in France leading to 166,811 deaths, and so on. Pneumonia is the second most common infectious diseases prevailing in various developing countries across the world. As per the report presented by UNICEF in 2019, it has been concluded that pneumonia kills more children than any other infectious disease, claiming the lives of over 700,000 children under five every year, or around 2,000 every day. This includes over 200,000 newborns. Globally, there are over 1,400 cases of pneumonia per 100,000 children, or 1 case per 71 children every year, with the greatest incidence occurring in South Asia (2,500 cases per 100,000 children) and West and Central Africa (1,620 cases per 100,000 children). Moreover, growing dependence of people on antimicrobial susceptibility testing for prevention of these diseases is further expected to register an impressive growth to global antimicrobial susceptibility testing market in the forecast period.

Growth in Geriatric Population

Growth in geriatric population across various parts of the world is also one of the significant drivers of global antimicrobial susceptibility testing market in the forecast period. This is because the elderly population is more vulnerable to infectious diseases, and their weakened immune systems make them more susceptible to bacterial infections. Improvement in healthcare and medical technology have led to longer life expectancies among geriatric people which is thereby growing the demand of antimicrobial susceptibility testing among them to stop the development of infection in their body at early stage. Influenza, shingles, tuberculosis, gastrointestinal infections, and urinary tract infections are some of the diseases which effects most of the people after 65 years of age. According to the report published by Population Reference Bureau (PRB) based on countries with the oldest populations in the world, it has been concluded that Japan is the foremost country in the world accounting for around 28.2% of geriatric people out of total population, followed by Italy with 22.8% of geriatric population, Greece, and Portugal with 21.8 %, and Germany with 21.4% of geriatric people out of the total population. Henceforth, growing ratio of geriatric population in various developing countries across the globe and growing prevalence of diseases associated with people during their elder age is also expected to bolster the growth of global antimicrobial susceptibility testing market in upcoming years.

Download Free Sample Report

Recent Developments

• In October 2020, the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, was introduced to improve the health and wellbeing of all Americans by changing the course of antibiotic resistance. This plan continues to prioritize infection prevention and control to slow the spread of resistant infections and optimize the antibiotic use.
• In 2019, the UK Government published a 20-year vision for tackling AMR and a 5-year action plan. Earlier, in 2018, the U.K. government launched a five-year national action plan detailing the contribution of the U.K. in controlling the growing global problem of antimicrobial resistance. The plan’s aim was to achieve a 10% fall in drug-resistant infections by 2025 and a 15% drop in human antibiotic use. The plan also targets to eliminate healthcare-related infections by 2024 and is expected to pave the way for investments in small biotech companies, which are working to reduce resistant infections.
• In December 2019, the Government of Australia invested USD 8 million to support antimicrobial resistance in Australia and the Pacific Island countries for combating the AMR situation.
• In December 2019, the U.S. National Institute of Allergy and Infectious Diseases allocated USD 102.5 million for over seven years for the Antibacterial Resistance Leadership Group, a global consortium of experts leading a clinical antibacterial resistance research network.
• In September 2019, a U.K. aid program, the Fleming Fund, working for low and middle-income countries, announced to invest USD 3.3 million in One Health AMR surveillance systems to improve laboratory infrastructure and offer six fellowships to scientists in Pakistan.
• In May 2022, Qualigen Therapeutics announced that NanoSynex Ltd, a company with whom Qualigen recently entered into definitive agreements to acquire a majority stake, featured at BioMed Israel. Innovative Technology by NanoSynex focuses to accelerate antimicrobial susceptibility test results times by six-fold.
• In April 2022, COPAN Diagnostics demonstrated its range of fully automated solutions for identification and antimicrobial susceptibility testing (AST) in clinical microbiology at the 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID 2022). COPAN demonstrated the Food and Drug Administration-cleared Colibri, a fully automated specimen workup instrument designed to prepare MALDI-TOF ID targets and create bacterial suspensions for AST.

• In 2021, Thermo Fisher Scientific Inc. and Q-linea introduce AStar Technology, a rapid antimicrobial susceptibility (AST) testing system that provides true minimum inhibitory concentration (MIC) data in less than 6 hours. Traditional AST technology can take up to 72 hours to get results.
• In August 2022, BD, a leading global medical technology company, announced worldwide commercial collaboration with Accelerate Diagnostics, Inc. which will help both the companies to address the global threat of antimicrobial resistance.

• In July 2020, Cepheid, a subsidiary of Danaher launched a novel rapid molecular test for TB which can detect multi-drug resistance to first line and second-line drugs simultaneously. The profiling can be achieved in less than 90 minutes. This will drive the antimicrobial testing market in the coming years.

Market Segmentation

The global antimicrobial susceptibility testing market is segmented based on product, technique, application, end user, company, and region. In terms of product, the antimicrobial susceptibility testing market is categorized into manual tests, (MIC strips, susceptibility testing disks, susceptibility plates), automated instruments, and consumables & media. Based on technique, global antimicrobial susceptibility testing market is fragmented into automated AST, Etest method, dilution, disk diffusion, and others. Based on, application market is segmented into drug development, susceptibility testing, and others. Based on end user, global antimicrobial susceptibility testing market is fragmented into hospitals, diagnostic laboratories, biotechnique & pharmaceutical companies, and others.

Market Players

Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, bioMerieux, Inc., Creative Diagnostics, Hi-Media Laboratories Pvt. Ltd., PerkinElmer, Inc., ELITech Group SAS, F. Hoffmann-La Roche Ltd., and Accelerate Diagnostics, Inc. are some of the key players in the global antimicrobial susceptibility testing market.

Report Scope:

In this report, global antimicrobial susceptibility testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Antimicrobial Susceptibility Testing Market, By Product:

o    Manual Tests (MIC Strips, Susceptibility Testing Disks, Susceptibility Plates)

o    Automated Instruments

o    Consumables & Media

• Antimicrobial Susceptibility Testing Market, By Technique:

o    Automated AST

o    Etest Method

o    Dilution

o    Disk Diffusion

o    Others

• Antimicrobial Susceptibility Testing Market, By Application:

o    Drug Development

o    Susceptibility Testing

o    Others

• Antimicrobial Susceptibility Testing Market, By End User:

o    Hospitals

o    Diagnostic Laboratories

o    BioTechnique & Pharmaceutical Companies

o    Others

• Antimicrobial Susceptibility Testing Market, By region:
• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• South Korea
• Australia
• Japan
• Europe
• Germany
• France
• United Kingdom
• Spain
• Italy
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global antimicrobial susceptibility testing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global antimicrobial susceptibility testing market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]